Addition of cyclosporin A to the combination of mitoxantrone and etoposide to overcome resistance to chemotherapy in refractory or relapsing acute myeloid leukaemia: a randomised phase II trial from HOVON, the Dutch-Belgian Haemato-Oncology Working (Q80407516)
Jump to navigation
Jump to search
scientific article published on 01 October 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Addition of cyclosporin A to the combination of mitoxantrone and etoposide to overcome resistance to chemotherapy in refractory or relapsing acute myeloid leukaemia: a randomised phase II trial from HOVON, the Dutch-Belgian Haemato-Oncology Working |
scientific article published on 01 October 2004 |
Statements
Addition of cyclosporin A to the combination of mitoxantrone and etoposide to overcome resistance to chemotherapy in refractory or relapsing acute myeloid leukaemia: a randomised phase II trial from HOVON, the Dutch-Belgian Haemato-Oncology Working Group for adults (English)
Bronno van der Holt
Simon Daenen
Gregor E G Verhoef
Bob Löwenberg
Pierre W Wijermans
Peter C Huijgens
Rien van Marwijk Kooy
Mark H H Kramer
Augustin Ferrant
Eva van den Berg
Monique M C Steijaert
Leo F Verdonck
Pieter Sonneveld
1 October 2004